STINGOSE GEL 20% 20 %
ALUMINUM SULFATE : 20 % · DIN 02040999 · KINSMOR PHARMACEUTICALS CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is STINGOSE GEL 20%?
STINGOSE GEL 20% 20 % contains ALUMINUM SULFATE : 20 %. It is listed in the Health Canada Drug Product Database under DIN 02040999, held by KINSMOR PHARMACEUTICALS CANADA INC., supplied as GEL for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02040999 |
|---|---|
| Brand name | STINGOSE GEL 20% |
| Generic / active ingredient | ALUMINUM SULFATE : 20 % |
| Manufacturer | KINSMOR PHARMACEUTICALS CANADA INC. |
| Strength | 20 % |
| Dosage form | GEL |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D08AB ALUMINIUM AGENTS |
| AHFS class | 84:08.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-1999 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D08AB ALUMINIUM AGENTS. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALUM PWR | 100 % | POWDER | PRODUITS MARC-O (1987) INC., DIVISION OF TECHNILAB INC. | CANCELLED POST MARKET | DIN 00430854 |
| ALUM PWR 100% | 100 % | POWDER | REGAL PHARMS, DIVISION OF BRADCAN CORPORATION | CANCELLED POST MARKET | DIN 00378275 |
| BLOOD STOP LIQ | 62.2 MG | LIQUID | LABORATOIRE ROMILO | CANCELLED POST MARKET | DIN 00407240 |
| DERMAGRAN OINTMENT | 0.275 % | OINTMENT | CANADIAN MEDICAL SUPPLY INC. | CANCELLED POST MARKET | DIN 00701734 |
| POWDERED ALUM | 100 % | POWDER | LAWTON'S DRUG STORES LTD. | CANCELLED POST MARKET | DIN 00728721 |
| STINGOSE ASP 373MG/ML | 373 MG | SPRAY | KINSMOR PHARMACEUTICALS CANADA INC. | CANCELLED POST MARKET | DIN 02018551 |
Who else supplies ALUMINIUM AGENTS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ALUMINIUM AGENTS appears in 62 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.